Specialty Pharmaceuticals Overview

The Specialty Pharmaceuticals Service reviews trends in benefit plan design and utilization management for specialty medications. Annual research provides detailed data on U.S. health plans management of specialty pharmaceuticals in their commercial business and the implications of the underlying coverage trends. Fixed and percent copay enrollments, copay pricing, specialty pharmacy provider usage, physician reimbursement and key utilization management tactics are highlighted. Nine key injectable categories are profiled in detail including:

• Asthma
• Crohn's Disease
• Erythropoiesis-Stimulating Agents (ESAs)
• Hepatitis C
• Multiple Sclerosis

• Osteoporosis
• Psoriasis
• Rheumatoid Arthritis
• White Blood Cell Stimulants

Who Should Subscribe?

Business development executives and strategic planners for specialty medication products will find the insightful implications and trend information useful for developing contracting and marketing strategies. Market research, product management and account executives will find the trends, practices, data and information useful for planning and assessing specific brand and customer strategies and tactics.

Why Subscribe?

This research assists manufacturers of specialty medications in evaluating marketing strategies, developing programs, allocating resources and designing product launch and pull-through initiatives. Key questions benchmarked in this research include:

• What are health plan current enrollment levels and trends for fixed dollar and percent copay benefit structures for specific specialty medications?
• What are the average fixed and percent copay levels for specific agents? Out-of-pocket limits?
• To what extent are specific utilization management controls and formulary tactics used for specific specialty pharmaceuticals?